Announcements

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2023)

We are pleased to inform you that Cells (ISSN: 2073-4409) has received an updated CiteScore of 9.0, an increase of 34% compared with the 2021 metric. The 2022 CiteScore™ was released recently, making an assessment of the scientific influence of journals in the 2019 to 2022 period.

Cells’ CiteScore ranks 34/212 among 212 titles (Q1) in the “General Biochemistry, Genetics and Molecular Biology” category.

For more journal statistics, please visit https://www.mdpi.com/journal/cells/stats.

Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.

MDPI journals will be attending the 42nd annual meeting of the American Society for Virology as an exhibitor. This meeting will be held in Athens, Georgia, USA from 24 to 28 June 2023.

The American Society for Virology (ASV) is a wonderful community that brings together virologists from all areas of the field. As a result, the annual meetings are rich in diverse scientific offerings and they can be quite large (sometimes over 1600 attendees). This conference is hosted by the University of Georgia and held at the Classic Center; the scientific program will include symposia, concurrent workshops, poster sessions, exhibits, and special events. Professional development activities and social events will be interspersed throughout the meeting.

The following MDPI journals will be represented:

• Biomedicines;
• Life;
• Viruses;
• Cells;
• Vaccines;
• Veterinary Sciences;
• Microorganisms;
• CIMB;
• Pathogens;
• TropicalMed;
• Zoonotic Diseases;
• COVID.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference and our booth, please visit: https://asv.org/asv2023/.

On 15 June 2023, MDPI and Cells (ISSN: 2073-4409) organized a webinar on cells, titled Systems Biology of Apoptotic and Non-apoptotic Signaling. The webinar focused on contemporary views on the intricate crosstalk of apoptotic and non-apoptotic networks in cell-regulating life/death decisions.

Life/death decisions in a cell are regulated by the balance between apoptotic and non-apoptotic signaling pathways. Although these pathways have been studied relatively well, their quantitative regulation has, until recently, been poorly understood. In this regard, the construction of mathematical models of apoptotic and non-apoptotic signaling pathways led to enormous progress in the quantitative understanding of cell fate control. Prof. Dr. Inna Lavrik first dissected the quantitative regulation of cell fate decisions in death receptor networks. Then, Prof. Boris Zhivotovsky showed us programmed cell death in the past, present, and future. Finally, Prof. Olga Lavrik presented poly(ADP-ribose)polymerases as dynamic triggers for biomolecular condensate formation. The three scholars comprehensively discussed the contemporary view on the intricate crosstalk of apoptotic and non-apoptotic networks in the cell regulating life/death decisions.

Please note that this webinar is associated with a Special Issue in Cells, “Systems Biology of Apoptotic and Non-apoptotic Signaling”. The deadline is 30 September 2023.

You can watch the recorded webinar at the following link: https://www.youtube.com/watch?v=ntLxD-eL8_A.

Webinar Chair and Keynote Speakers:

• Prof. Dr. Inna Lavrik, Translational Inflammation Research, Medical Faculty, Center of Dynamic Systems, Otto von Guericke University Magdeburg, Magdeburg, Germany;
• Prof. Boris Zhivotovsky, Institute of Environmental Medicine, Division of Toxicology, Karolinska Institute, Solna, Sweden;
• Prof. Olga Lavrik, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.

Conference: 60th European Renal Association (ERA) Congress

Date: 15–17 June 2023

Location: Milan, Italy

MDPI will be attending the 60th ERA Congress as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is being organized by the European Renal Association, and it will offer a clearly structured scientific program, combining presentations of cutting-edge research with a broad view of the currently most relevant fields in the prevention, detection, and treatment of kidney disease. At the conference, specialists will share knowledge on the clinical assessment and treatments of renal diseases to improve disease prevention and patients’ quality of life.

The following MDPI journals will be represented:

• JCM;
• JPM;
• Kidney and Dialysis;
• Diagnostics;
• Clinics and Practice;
• Uro;
• Cells;
• BioChem;
• Transplantology.

MDPI will be attending the 64th Annual Spring Meeting of the Japanese Society of Clinical Cytology, which will be held from 9 to 11 June 2023 in Nagoya, Japan, at the Nagoya Congress Center.

The conference is the official annual meeting of the Japanese Society of Clinical Cytology (JSCC), which is an academic organization consisting of physicians specializing in cytology and cytotechnologists who perform cytology for the purposes of cancer diagnosis and screening. Physicians specializing in cytology that belong to the society include gynecologists, surgeons, internists, and pathologists as well as cytotechnologists.

In light of current trends, the theme of this annual meeting is “Be fascinated with the mastery of cytology!—Mastering the art and passing it on to the next generations”. Cytology is deeply related to cervical cancer screening in Japan. Raising the screening rate, improving and adhering to the screening management guidelines, including colposcopy, and increasing the vaccination rate are important issues for the eradication of cervical cancer. These preventive strategies for cervical cancer will be propagated in this meeting.

The following MDPI journals will be represented:

• Cells;
• Cancers;
• Diagnostics;
• Medicina;
• Medical Sciences.

Please do not hesitate to reach out (cells@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.c-linkage.co.jp/jscc2023/index.html.

Conference: 19^th Annual International Conference of the Metabolomics Society

Date: 18–22 June 2023

Place: Niagara Falls Convention Centre, 6815 Stanley Avenue, Niagara Falls, Ontario, Canada L2G 3Y9

Booth: #T12

MDPI will be attending the 19^th Annual International Conference of the Metabolomics Society, which will be held from 18 to 22 June 2023 in downtown Niagara Falls, Canada, at the Niagara Falls Convention Centre.

The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. It will cover the major scientific themes of: technology advances; computational metabolomics, statistics, and bioinformatics; metabolomics in health and disease; and metabolomics of plants, food, environment and microbes. A special theme for this conference will focus on mental health, drug addiction and medicinal cannabis. The scientific program will include plenary and keynote talks, three parallel scientific sessions, interactive poster sessions, sponsor lunches, other networking events and a specially organized parallel session to promote metabolomics research in industry. A strong line-up of both introductory and advanced workshops will take place on Sunday, 18 June, and the morning of Monday, 19 June. To complement the exciting scientific program, the conference will offer a welcome reception, vibrant early career events, a conference dinner and other engaging social activities.

The following MDPI journals will be represented:

• Metabolites;
• Agronomy;
• Antioxidants;
• Applied Biosciences;
• BioMed;
• BioMedInformatics;
• Biomolecules;
• Cancers;
• Cells;
• Children;
• CIMB;
• Diseases;
• Foods;
• Genes;
• JPM;
• Nutrients;
• Plants.

Please do not hesitate to reach out (metabolites@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.metabolomics2023.org/.

Conference: 29th Congress of the European Association for Cancer Research
Date: 12–15 June 2023
Place: Torino, Italy

MDPI will be attending the 29th Congress of the European Association for Cancer Research, held in Torino, Italy, from 12 to 15 June 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of cancer research over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest ideas with us.

The following MDPI journals will be represented:

• Cells;
• Cancers;
• Children;
• CIMB;
• Current Oncology;
• Diagnostics;
• Geriatrics;
• Healthcare;
• JCM;
• Medical Sciences.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.eacr2023.org/.

MDPI will be attending the European Human Genetics Conference 2023 (ESHG 2023), held in Glasgow, UK, from 10 to 13 June 2023.

The following MDPI journals will be represented:

• Genes;
• IJMS;
• JPM;
• Applied Biosciences;
• MPs;
• Symmetry;
• Toxics;
• Cells;
• IJNS.

If you plan on attending this conference, feel free to stop by our booth #824. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please visit the following link: https://2023.eshg.org/.